A qPCR panel for the detection of UTI & Wound infections
The YouSeq UTI & Wound qPCR Panel covers the most clinically relevant UTI and wound pathogens — plus integrated AMR markers — enabling comprehensive profiling in a single run. The YouSeq UTI & Wound qPCR panel contains pre plated primers and probes for different infectious diseases commonly found in infected samples. Each well contains up to a 4-way multiplex primer/probe mix. Thus each row of the plate contains primer/probes for detection of different targets plus controls. Ideal for rapid investigation of UTI / wound infection samples in clinical research labs.
Available for delivery in United States
Price on enquiry
Order nowNeed a custom version of this panel? No problem...
Contact usFor Research Use Only. Not intended for diagnostic use.
Acinetobacter baumannii
Bacteroides fragilis
Candida albicans
Candida dubliniensis
Candida glabrata
Candida krusei
Candida parapsilosis
Candida tropicalis
Citrobacter freundii
Citrobacter koseri
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella oxytoca complex
Klebsiella pneumoniae
Morganella morganii
Proteus mirabilis
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus agalactiae
Streptococcus pyogenes
RNaseP Endogenous Control
Class A beta-lactamase (blaSHV/blaKPC) resistance
Class A beta-lactamase (CTX-M-Grp 1/2/8/9/25) resistance
Class B beta-lactamase (blaNDM/blaIMP/blaVIM) resistance
Fluoroquinolones (QnrA/QnrB/QnrS)
Macrolide/Lincosamide/Streptogramin (ermA/ermB/ermC) resistance
Methicillin (mecA) resistance
Vancomycin A/B Resistance
Pseudonyms
Escherichia coli; E. coli; Enterococcus; Staphylococcus aureus; Staph; Streptococcus; Klebsiella; Proteus; Pseudomonas aeruginosa; Candida; Yeast; MRSA; Methicillin-resistant Staphylococcus aureus; VRE; Vancomycin-resistant enterococcusRelated products
Still scrolling? We love adventurers
We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.
More about usRelated learning resources